| STIs | Sexually transmitted infections |
| PID | Pelvic inflammatory disease |
| TFI | Tubal factor infertility |
| CDC | Centers for Disease Control and Prevention |
| LGV | lymphogranuloma venereum |
| WGS | Whole genome sequencing |
| NG-MAST | Neisseria gonorrhoeae multiantigen sequence typing |
| MLST | Multilocus sequence typing |
| NG-STAR | Neisseria gonorrhoeae sequence typing for antimicrobial resistance |
| MOMP | Major outer membrane protein |
| MSM | Men who have sex with men |
| CT | Chlamydia trachomatis |
| TLR-4 | Toll-like receptor 4 |
| SGA | Small for gestational age |
| LBW | Low birth weight |
| NAATs | Nucleic acid amplification tests |
| EIA | Enzyme immunoassay |
| DIF | Direct immunofluorescence |
| SDA | Strand displacement amplification |
| TMAnvCT | Transcription-mediated amplificationNew variant C. trachomatis |
| SNP | Single-nucleotide polymorphism |
| HPA | Hybridization protection assay |
| Euro-GASPMIC | European Gonococcal Antimicrobial Surveillance ProgrammeMinimum inhibitory concentration |
| ETFs | Electron transfer proteins |
| MG | Mycoplasma genitalium |